의약품 용출 시험 서비스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Pharmaceutical Dissolution Testing Services Market size is expected to reach USD 1117.18 Million in 2034 from USD 503.47 Million (2025) growing at a CAGR of 9.26% during 2026-2034.

The Global Pharmaceutical Dissolution Testing Services Market is growing as pharmaceutical companies focus on ensuring drug quality, safety, and regulatory compliance. Dissolution testing plays a vital role in evaluating how drugs release active ingredients in the body. With increasing drug development activities and stricter regulatory requirements, demand for reliable testing services is rising steadily.

Key growth drivers include the expansion of generic drug production, rising research activities, and the need for quality control throughout the drug development process. Outsourcing testing services to specialized laboratories helps pharmaceutical companies save time and reduce operational costs. This trend is particularly strong among small and mid-sized pharmaceutical firms.

Looking forward, technological advancements in testing equipment and automation will further enhance service efficiency and accuracy. As the pharmaceutical industry continues to innovate and launch new drug formulations, the need for advanced dissolution testing services will remain strong. The market is expected to grow consistently in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Method

• In-Vitro
• In-Vivo

By Dosage Form

• Capsule
• Tablets
• Others

By Dissolution Apparatus

• Basket
• Paddle
• Others

COMPANIES PROFILED

• Intertek Group Plc, Avivia BV, Almac Group, Agilent Technologies Inc, Catalent Inc, Thermo Fisher Scientific Inc, Cambrex Corp, Charles River Laboratories, Boston Analytical, Pace Analytical Life Sciences, SOTAX, AMRI, SGS SA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET: BY METHOD 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Method
• 4.2. In-Vitro Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. In-Vivo Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET: BY DOSAGE FORM 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Dosage Form
• 5.2. Capsule Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET: BY DISSOLUTION APPARATUS 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Dissolution Apparatus
• 6.2. Basket Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Paddle Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Method
  • 7.2.2 By Dosage Form
  • 7.2.3 By Dissolution Apparatus
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Method
  • 7.3.2 By Dosage Form
  • 7.3.3 By Dissolution Apparatus
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Method
  • 7.4.2 By Dosage Form
  • 7.4.3 By Dissolution Apparatus
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Method
  • 7.5.2 By Dosage Form
  • 7.5.3 By Dissolution Apparatus
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Method
  • 7.6.2 By Dosage Form
  • 7.6.3 By Dissolution Apparatus
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Intertek Group Plc
  • 9.2.2 Avivia BV
  • 9.2.3 Almac Group
  • 9.2.4 Agilent Technologies Inc
  • 9.2.5 Catalent Inc
  • 9.2.6 Thermo Fisher Scientific Inc
  • 9.2.7 Cambrex Corp
  • 9.2.8 Charles River Laboratories
  • 9.2.9 Boston Analytical
  • 9.2.10 Pace Analytical Life Sciences
  • 9.2.11 SOTAX
  • 9.2.12 AMRI
  • 9.2.13 SGS SA